Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof










Image Number 10 for United States Patent #6030955.

The present invention provides methods of stimulating or inhibiting intracellular phosphorylation of tyrosine by a heparin-binding receptor which comprises contacting a cell having on its surface the heparin-binding receptor with a phosphorothioate oligonucleotide moiety of suitable length and base composition, such phosphorothioate oligonucleotide moiety being present in an effective amount. The invention further provides a method of inhibiting the formation of blood vessels in a subject which comprises administering to the subject an amount of a phosphorothioate oligonucleotide moiety of suitable length and base composition. The invention also provides a method of inhibiting proliferation of cells having a malignant phenotype in a subject which comprises administering to the subject an amount of a phosphorothioate oligonucleotide moiety of suitable length and base composition.








 
 
  Recently Added Patents
Method of manufacturing liquid ejection head
Light emitting device and method of manufacturing the same
System, method, and apparatus for settlement for participation in an electric power grid
Shoe upper
Methods and systems for forcing an application to store data in a secure storage location
Single-phase and three-phase dual buck-boost/buck power factor correction circuits and controlling method thereof
Distance detection device and collision determination device
  Randomly Featured Patents
Vehicle wheel
Delay detonator device
Inhibitors of nitric oxide synthase for treatment of melanoma
Backward starting locknut
Methods and apparatus for performing endoluminal gastroplasty
Optical tomography system
Composite electrical insulator
Method for exit negotiation with aggregate application descendents
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors
Mass programmable FM stereo sound equalized assistive listening apparatus